Joe W. Krayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joe W. Krayer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Renata S. Leite
Department of Stomatology, Medical University of South Carolina
2 shared publications - Dustin C. Hedgpeth
Department of Stomatology, James B. Edwards College of Dental Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA.
1 shared publication - Junfei Jin
Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University , Guilin, Guangxi 541001
1 shared publication - Keith Lough Kirkwood
Department of Oral Biology, University at Buffalo, Buffalo, NY, USA
1 shared publication - Xiaoming Zhang
Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, College of Medicine, Medical University of South Carolina, 114 Doughty Street, Charleston, SC, 29425, USA.
1 shared publication - Yan Huang
Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina
1 shared publication
Latest Publications
- Open Access
- 18 November 2015
- Published by Springer Nature in BMC Oral Health
- Vol. 15 (1) , 145
Periodontal CD14 mRNA expression is downregulated in patients with chronic periodontitis and type 2 diabetes
Patients with type 2 diabetes mellitus (T2DM) have increased severity of periodontitis. Toll-like receptor (TLR)4, its co-receptors CD14 and MD-2, and adaptor MyD88 play pivotal roles in lipopolysaccharide (LPS)-triggered tissue inflammation and periodontitis. This study investigated the effects of T2DM and periodontitis on TLR4, CD14, MD-2 and MyD88 mRNA expression in surgically removed periodontal tissues. Periodontal tissue specimens were collected from 14 patients without periodontitis and T2DM (Group 1), 15 patients with periodontitis alone (Group 2), and 7 patients with both periodontitis and T2DM (Group 3). The mRNA of TLR4, CD14, MD-2 and MyD88 was quantified using real-time PCR and compared between the groups. Statistical analysis showed that periodontal expression of CD14 mRNA was significantly reduced across Groups 1, 2 and 3 (p = 0.02) whereas the mRNA expression of TLR4, MD-2 and MyD88 was not significantly different among the groups. Furthermore, when patients in Groups 1 and 2 were combined (n = 22), the CD14 mRNA expression was significantly lower than that in patients of Group 1 (p = 0.04). CD14 mRNA expression was downregulated across patients with neither periodontitis nor T2DM, patients with periodontitis alone and patients with both diseases, suggesting that CD14 mRNA expression is associated with a favorable host response or subjected to a negative feedback regulation.
- 18 November 2015
- Published by Springer Nature in BMC Oral Health
- Vol. 15 (1) , 145
Open AccessPeriodontal CD14 mRNA expression is downregulated in patients with chronic periodontitis and type 2 diabetes
Patients with type 2 diabetes mellitus (T2DM) have increased severity of periodontitis. Toll-like receptor (TLR)4, its co-receptors CD14 and MD-2, and adaptor MyD88 play pivotal roles in lipopolysaccharide (LPS)-triggered tissue inflammation and periodontitis. This study investigated the effects of T2DM and periodontitis on TLR4, CD14, MD-2 and MyD88 mRNA expression in surgically removed periodontal tissues. Periodontal tissue specimens were collected from 14 patients without periodontitis and T2DM (Group 1), 15 patients with periodontitis alone (Group 2), and 7 patients with both periodontitis and T2DM (Group 3). The mRNA of TLR4, CD14, MD-2 and MyD88 was quantified using real-time PCR and compared between the groups. Statistical analysis showed that periodontal expression of CD14 mRNA was significantly reduced across Groups 1, 2 and 3 (p = 0.02) whereas the mRNA expression of TLR4, MD-2 and MyD88 was not significantly different among the groups. Furthermore, when patients in Groups 1 and 2 were combined (n = 22), the CD14 mRNA expression was significantly lower than that in patients of Group 1 (p = 0.04). CD14 mRNA expression was downregulated across patients with neither periodontitis nor T2DM, patients with periodontitis alone and patients with both diseases, suggesting that CD14 mRNA expression is associated with a favorable host response or subjected to a negative feedback regulation.
- 1 January 2010
- Published by Elsevier in Dental Clinics of North America
- Vol. 54 (1) , 13-33
Non-Surgical Chemotherapeutic Treatment Strategies for the Management of Periodontal Diseases
- 1 January 2010
- Published by Elsevier in Dental Clinics of North America
- Vol. 54 (1) , 13-33
Non-Surgical Chemotherapeutic Treatment Strategies for the Management of Periodontal Diseases